Your browser doesn't support javascript.
loading
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors.
Mani, Rajeswaran; Goswami, Swagata; Gopalakrishnan, Bhavani; Ramaswamy, Rahul; Wasmuth, Ronni; Tran, Minh; Mo, Xiaokui; Gordon, Amber; Bucci, Donna; Lucas, David M; Mims, Alice; Brooks, Christopher; Dorrance, Adrienne; Walker, Alison; Blum, William; Byrd, John C; Lozanski, Gerard; Vasu, Sumithira; Muthusamy, Natarajan.
Afiliação
  • Mani R; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Goswami S; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Gopalakrishnan B; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Ramaswamy R; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Wasmuth R; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Tran M; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Mo X; Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
  • Gordon A; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Bucci D; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Lucas DM; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Mims A; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Brooks C; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Dorrance A; Stemline Therapeutics, Inc., New York, NY, USA.
  • Walker A; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Blum W; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Byrd JC; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Lozanski G; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Vasu S; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Muthusamy N; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.
Haematologica ; 103(8): 1288-1297, 2018 08.
Article em En | MEDLINE | ID: mdl-29773600
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Proteínas Recombinantes de Fusão / Leucemia Mieloide Aguda / Linfócitos T CD4-Positivos / Subunidade alfa de Receptor de Interleucina-3 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Proteínas Recombinantes de Fusão / Leucemia Mieloide Aguda / Linfócitos T CD4-Positivos / Subunidade alfa de Receptor de Interleucina-3 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos